159
http://www.DGS-PraxisLeitlinien.deNr.
Nachweis
85
Erdine S. Interventional treatment of cancer pain. European Journal of Cancer Supple-
ments 2005; 3: 97-106.
86
European Medicines Agency. Abstral 100, 200, 300, 400, 600, 800 microgram sublin-
gual tablets: summary of product characteristics [online]. Verfügbar online über URL:
http://emc.medicines.org.uk/document.aspx?documentId=21371[aufgerufen am
31.10.2025].
87
European Medicines Agency. Actiq 200, 400, 600, 800, 1200, 1600 microgram com-
pressed lozenge: summary of product characteristics [online]. Verfügbar online über
URL:
http://www.medicines.org.uk/emc/medicine/11145/SPC/Actiq[aufgerufen am
31.10.2025].
88
European Medicines Agency. Effentora buccal tablets: summary of product characte-
ristics [online]. Verfügbar online über URL:
http://www.emea.europa.eu/humandocs/
Humans/EPAR/effentora/effentora.htm [aufgerufen am 31.10.2025].
89
European Medicines Agency. European public assessment report (EPAR): Instanyl
(fentanyl) [online]. Verfügbar online über URL:
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000959/human_med_000838.
jsp&murl=menus/medicines/medicines.jsp∣=WC0b01ac058001d124 [aufgerufen
am 31.10.2025].
90
European Medicines Agency. European public assessment report (EPAR): Effentora
(fentanyl) [online].Verfügbar online über URL:
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000833/human_med_000754.
jsp&murl=menus/medicines/medicines.jsp∣=WC0b01ac058001d124 [aufgerufen
am 31.10.2025].
91
European Medicines Agency. Instanyl nasal spray, solution: summary of product cha-
racteristics [online]. Verfügbar online über URL:
http://www.emea.europa. eu/human-
docs/PDFs/EPAR/instanyl/emea-combined-h959en.pdf [aufgerufen am 31.10.2025].
92
Fallon M, Reale C, Davies A, Lux AE, Kumar K, Stachowiak A, Galvez R; Fentanyl Nasal
Spray Study 044 Investigators Group. Efficacy and safety of fentanyl pectin nasal
spray compared with immediate-release morphine sulfate tablets in the treatment of
breakthrough cancer pain: a multicenter, randomized, controlled, double-blind, double-
dummy multiple-crossover study. J Support Oncol. 2011; 9(6): 224-231.
93
Fallon MT, Gatti A, Gatti A et al. Fentanyl pectin nasal spray provides clinically meaning-
ful pain relief and a more rapid onset of analgesia compared with immediate-release
morphine sulfate in breakthrough cancer pain. Palliative Med 2010; 24 (S24).
94
Farquhar-Smith P. Anaesthetic / interventional techniques. In: Davies AN (Hrsg.),
Cancer-related bone pain. Oxford: Oxford University Press; 2007, 85-97.
95
Farrar JT, Cleary J, Rauck R, Busch M, Nordbrock E. Oral transmucosal fentanyl citrate:
randomized, double-blinded, placebo controlled trial for treatment of breakthrough
pain in cancer patients. J Natl Cancer Inst 1998; 90 (8): 611-616.
96
FENTORA (fentanyl buccal tablet): US prescribing information. Frazer (PA): Cephalon
Inc. [online]. Verfügbar online über URL:
http://dailymed.nlm.nih.gov/dailymed/drugIn-fo.cfm?id=59775 [aufgerufen am 31.10.2025].
Literaturverzeichnis